For reasons not clear, the face of HIV and AIDS do not usually high rate of AIDS-related cancer, a new study suggests.

For reasons not clear, the face of HIV and AIDS do not usually high rate of AIDS-related cancer, a new study suggests.

The growth rate of "non-AIDS cancer", including lung cancer, head and neck, liver, kidney, anal cancer, and so, according to research the status of the American Scientific Association (AAAS) appear on the site Monday.

Alarming cancer rates in the rising prominence, the urgent need to understand how to treat AIDS patients taking highly active antiretroviral therapy (HAART) in the tumor, researchers said.

To explore new therapeutic cocktail therapy and potential drug interactions of cancer, malignancy, AIDS Society (AMC), and by the National Cancer Institute (NCI) to support clinical trials group, founded in 1995 to support AIDS-related Innovative cancer tests, conducted the first series of research projects.

John Deeken, MD, Lombardi Comprehensive Cancer Center at Georgetown President and research physician in medical research, presented during the poster session of the findings in the ongoing American Society of Clinical Oncology 2011 (ASCO) Annual Meeting in Chicago, United States, according to the U.S. Science Association.

Deeken said, these early results have been possible to change the treatment of cancer patients infected with the HIV virus.

"So far, oncologists have not taken a cocktail of cancer on many people's information, said:" Deeken. "We are basically a square, because people with HIV are usually not included in cancer clinical trials. They are excluded, because the doctor about the AIDS patients in the immune suppression caused further worry because the drug cocktail that led to notorious drug interactions impeccable serious side effects. "

The first is the study of drug sunitinib, which may stop blood flow by blocking tumor cell growth and blocking the enzyme required for the growth of some cancer cells. However, in the HAART cocktail of drugs is considered to affect the metabolism of sunitinib-related enzymes, according to the report.

Posted in: a new study suggests.,For reasons not clear,the face of HIV and AIDS do not usually high rate of AIDS-related cancer